Virtual Clinical Trials, are not a new concept, but have experienced a boost during COVID-19. The pandemic has pushed pharma companies to increase adoption of virtual trials, as patient feels insecure when visiting sites. 

Going virtual with your clinical trial can boost a lot of postives. It  enable fewer on-site visits for the patient or eliminate them completely. The patient base can widen over a larger area as there is no need to go to a site and with app and email reminders the patient adherence can be increased. 

However going virtual is not a “one-size fits all” solution. In This white paper we will take a closer look at some of the pitfalls when planning a virtual trial.  

Download the whitepaper

    You must agree before submitting.

    For more information on how we are committed to protecting and respecting your privacy, please review our Privacy Policy.